Clinical factors associated with satisfaction of cancer patients for the treatment of opioid-induced constipation: A post hoc analysis utilizing outcomes of naldemedine phase III study

被引：0
|
作者：
Ishiki, H. [1 ]
Satomi, E. [1 ]
Tada, Y. [2 ]
Yokota, T. [3 ]
Sato, H. [4 ]
Okamoto, M. [5 ]
Osaka, I. [6 ]
机构：
[1] Natl Canc Ctr, Dept Palliat Med, Tokyo, Japan
[2] Shionogi & Co Ltd, Biostat Ctr, Osaka, Japan
[3] Shionogi & Co Ltd, Global Project Management, Osaka, Japan
[4] Shionogi & Co Ltd, Global Med Affairs, Osaka, Japan
[5] Shionogi & Co Ltd, Med Affairs, Osaka, Japan
[6] Shizuoka Canc Ctr, Dept Palliat Med, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
424P
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [31] SYMPTOM AND TREATMENT BURDEN ASSOCIATED WITH OPIOID-INDUCED CONSTIPATION IN CANCER PATIENTS WITH ADVANCED DISEASE
    Dhingra, Lara
    Shuk, Elyse
    Grossman, Bella
    Strada, Alessandra
    Portenoy, Allison
    Borlakov, Magamet
    Portenoy, Russell
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 11 - 11
  • [32] Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study
    Hiruta, Eriko
    Fujita, Yukiyoshi
    Imai, Hisao
    Masuno, Takashi
    Yamazaki, Shigeki
    Tanaka, Hajime
    Kamiya, Teruhiko
    Ito, Masako
    Takei, Satoshi
    Matsuura, Masato
    Nishiba, Hiromi
    Mogi, Junnosuke
    Kotake, Mie
    Koizuka, Shiro
    Minato, Koichi
    MEDICINA-LITHUANIA, 2021, 57 (11):
  • [33] A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy
    Webster, Lynn R.
    Hale, Martin E.
    Yamada, Tadaaki
    Wild, James E.
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 605 - 612
  • [34] Naldemedine is associated with earlier defecation in critically ill patients with opioid-induced constipation: A retrospective, single-center cohort study
    Nishiyama, Seiya
    Uchino, Shigehiko
    Sasabuchi, Yusuke
    Masuyama, Tomoyuki
    Lefor, Alan Kawarai
    Sanui, Masamitsu
    PLOS ONE, 2024, 19 (01):
  • [35] Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age
    Wild, James
    Webster, Lynn
    Yamada, Tadaaki
    Hale, Martin
    DRUGS & AGING, 2020, 37 (04) : 271 - 279
  • [36] SAFETY OF NALDEMEDINE FOR THE TREATMENT OF OPIOID-INDUCED CONSTIPATION IN SUBJECTS WITH CHRONIC NON-CANCER PAIN RECEIVING OPIOID THERAPY: RESULTS OF THREE GLOBAL PHASE 3 CLINICAL TRIALS
    Webster, Lynn
    Magazine, Harold I.
    Yamada, Tadaaki
    GASTROENTEROLOGY, 2018, 154 (06) : S756 - S756
  • [37] Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of Age
    James Wild
    Lynn Webster
    Tadaaki Yamada
    Martin Hale
    Drugs & Aging, 2020, 37 : 271 - 279
  • [38] Characterization of Abdominal Pain During Methylnaltrexone Treatment of Opioid-Induced Constipation in Advanced Illness: A Post Hoc Analysis of Two Clinical Trials
    Slatkin, Neal E.
    Lynn, Richard
    Su, Chinyu
    Wang, Wenjin
    Israel, Robert J.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2011, 42 (05) : 754 - 760
  • [39] Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives
    Hale, Martin E.
    Wild, James E.
    Yamada, Tadaaki
    Yokota, Takaaki
    Tack, Jan
    Andresen, Viola
    Drewes, Asbjorn Mohr
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [40] Naldemedine for opioid-induced constipation in patients receiving palliative care:A real-world registry study (Phase-R OIC Study).
    Shimizu, Masaki
    Kessoku, Takaomi
    Ishiki, Hiroto
    Matsuura, Tetsuya
    Hiratsuka, Yusuke
    Matsuda, Yoshinobu
    Hasegawa, Takaaki
    Imai, Kengo
    Maeda, Isseki
    Oyamada, Shunsuke
    Satomi, Eriko
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345